Emanuela Palmerini
机构: IRCCS Istitituto Ortopedico Rizzoli
每年引用次数
引用次数
引用: 10,784
H-指数: 54
I10-指数 : 127
出版物: 299
Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
Piero Picci , Gianni Bisogno , Cristina Meazza , Rodolfo Capanna
Tumori 100 ( 6) 612 -619
15
2014
Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years.
Marco Alberghini , Piero Picci , Eric Staals , Nicola Fabbri
Tumori 98 ( 6) 702 -708
11
2012
Piroxicam Increases Colon Tumorigenesis and Promotes Apoptosis in Mlh1+/-/Apc1638N/+ Mice
Guido Biasco , Winfried Edelmann , Mauro Risio , Emanuela Palmerini
Anticancer Research 27 3807 -3812
5
2007
A simple prognostic scoring system for non metastatic osteosarcoma of the extremity
M Alberghini , Piero Picci , Mario Mercuri , A Longhi
Orthopaedic Proceedings 56 -56
2012
New therapeutic approaches in sarcoma: Immunomodulation and tumor microenvironment
Emanuela Palmerini
2018
Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab.
Piero Picci , Marco Gambarotti , Peter Reichardt , Leanne L Seeger
BMC Cancer 21 ( 1) 89
2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial.
Leonardo A. Meza-Zepeda , Marilena Cesari , Kjetil Boye , Tormod Guren
Cancer Immunology, Immunotherapy 1 -8
1
2021
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade.
Katia Scotlandi , Michele Cavo , Darina Ocadlikova , Mariangela Lecciso
Frontiers in Immunology 12 577766 -577766
16
2021
Trabectedin for Patients with Advanced Soft Tissue Sarcoma: A Non-Interventional, Retrospective, Multicenter Study of the Italian Sarcoma Group.
Irene Quattrini , Alessandro Comandone , Piero Picci , Giuseppe Badalamenti
Cancers 13 ( 5) 1053
2021
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases
Enrico Derenzini , Guido Biasco , Giovanni Brandi , Gian Luca Grazi
6th National Congress of Medical Oncology 15 66 -66
2
2004
Ewings sarcoma in patients over 40 years
M Alberghini , M Cesari , E Marchesi , M Abate
25th annual meeting of the european musculoskeletal oncology society 20 -20
2012
Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial.
Javier Martín-Broto , Kristen Ganjoo , Silvia Stacchiotti , William D Tap
Acta Orthopaedica 1 -7
2021
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study.
Daniel Baumhoer , Stefanie Hecker-Nolting , Gaetano Apice , Bodil Bjerkehagen
European Journal of Cancer 151 150 -158
2021
Final results of ENLIVEN: A global, double-blind, randomized, placebo-controlled, phase 3 study of pexidartinib in advanced tenosynovial giant cell tumor (TGCT).
William D. Tap , Hans Gelderblom , Silvia Stacchiotti , Emanuela Palmerini
Journal of Clinical Oncology 36 11502 -11502
18
2018
First prospective observational study in diffuse-type tenosynovial giant cell tumors.
Monique Mastboom , Emanuela Palmerini , Silvia Stacchiotti , Eric Staals
Journal of Clinical Oncology 36 11560 -11560
1
2018
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma Group.
Federica Grosso , Lorenzo D’Ambrosio , Massimo Zucchetti , Toni Ibrahim
Cancer 126 ( 21) 4726 -4734
1
2020
Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
Hans Gelderblom , Andrew J. Wagner , William D. Tap , Emanuela Palmerini
Cancer 127 ( 6) 884 -893
3
2021
Outcome of advanced, unresectable conventional central chondrosarcoma.
Annemiek M. van Maldegem , Hans Gelderblom , Emanuela Palmerini , Sander D. Dijkstra
Cancer 120 ( 20) 3159 -3164
56
2014
Role of (Neo)adjuvant Denosumab for Giant Cell Tumor of Bone.
Emanuela Palmerini , Eric Lodewijk Staals , Louis Baxter Jones , Davide Maria Donati
Current Treatment Options in Oncology 21 ( 8) 68
2020
How Does the Skeletal Oncology Research Group Algorithm's Prediction of 5-year Survival in Patients with Chondrosarcoma Perform on International Validation?
Michiel E. R. Bongers , Aditya V. Karhade , Elisabetta Setola , Marco Gambarotti
Clinical Orthopaedics and Related Research 478 ( 10) 2300 -2308
4
2020
Piero Picci Marco Gambarotti Jean-yves Blay Emanuela Marchesi Hans Gelderblom Javier Martín Broto Pietro Ruggieri Michiel van de Sande Alessandro Gronchi alberto righi John H. Healey Angelo Dei Tos Jayesh Desai katia scotlandi Andreas Mavrogenis Thierry Alcindor Kristen Ganjoo CovidSurg Collaborative Robin Jones